Table 2 Results of the CT-rich SNCA haplotypes’ and risk SNVs’ association with the PD phenotype
Haplotype/SNV | t | P | SE | OR | 2.50% | 97.50% |
|---|---|---|---|---|---|---|
Haplotype 1 | -0.781 | 4.35E-01 | 0.018 | 0.990 | -0.0496 | 0.0213 |
Haplotype 2 | 1.273 | 2.11E-01 | 0.019 | 0.860 | -0.0132 | 0.0621 |
Haplotype 3 | 1.252 | 2.16E-01 | 0.029 | 1.040 | -0.0202 | 0.0916 |
Haplotype 4 | -1.254 | 2.10E-01 | 0.019 | 0.980 | -0.0602 | 0.0132 |
rs356182 (PD) | 2.773 | 5.62E-03 | 0.018 | 1.050 | 0.0147 | 0.0855 |
rs5019538 (PD) | 1.824 | 6.84E-02 | 0.018 | 1.030 | -0.0025 | 0.0692 |
rs2298728 (PD) | 0.887 | 3.75E-01 | 0.034 | 1.030 | -0.0364 | 0.0967 |
rs7680557 (LBD) | 0.772 | 4.41E-01 | 0.017 | 1.010 | -0.0208 | 0.0478 |
